Marlise R Luskin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 71

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer discovery

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood cancer discovery 5 (3) (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia (2024)
Rathnam K Venkat, Robert A Redd, Amyah C Harris, Martin J Aryee, Anna E Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle Dawn Weeks, Maximilian Stahl, Daniel J DeAngelo, R Coleman Lindsley, Marlise R Luskin, Gabriela S Hobbs, Joan How
Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis. Blood advances (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia 38 (3) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Ibrahim Aldoss, Gregory W Roloff, Rawan G Faramand, Noam E Kopmar, Chenyu Lin, Anjali S Advani, Simone E Dekker, Vishal K Gupta, Timothy E O'Connor, Nikeshan Jeyakumar, Ibrahim N Muhsen, Yannis K Valtis, Amy Zhang, Katharine Miller, Katherine C Sutherland, Kaitlyn C Dykes, Mohamed Ahmed, Evan C Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc S Schwartz, Sean I Tracy, Bhagirathbhai R Dholaria, Michal Jakub Kubiak, Akash Mukherjee, Navneet S Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A Malik, John Mathews, Paul J Shaughnessy, Aaron C Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M O'Dwyer, LaQuisa C Hill, Stephanie B Tsai, Joshua P Sasine, Melhem M Solh, Catherine J Lee, Vamsi Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T Leonard, Noelle V Frey, Jae H Park, Marlise R Luskin, Veronika Bachanova, Ahmed Galal, Michael R Bishop, Wendy Stock, Ryan D Cassaday, Vinod A Pullarkat, Bijal D Shah, Lori S Muffly
Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL. Blood advances (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Marlise R Luskin
Finding the perPh+ect balance in Ph+ ALL. Blood 143 (23) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Julia Keating, Christopher J Fay, Marlise R Luskin, Donna S Neuberg, Nicole R LeBoeuf, Andrew A Lane
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival. Blood advances 8 (11) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia 38 (3) (2024)
Shai Shimony, Julia Keating, Christopher J Fay, Marlise R Luskin, Donna S Neuberg, Nicole R LeBoeuf, Andrew A Lane
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival. Blood advances 8 (11) (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia 38 (3) (2024)
Shai Shimony, Julia Keating, Christopher J Fay, Marlise R Luskin, Donna S Neuberg, Nicole R LeBoeuf, Andrew A Lane
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival. Blood advances 8 (11) (2024)
Shai Shimony, Julia H Keating, Christopher J Fay, Marlise R Luskin, Donna S Neuberg, Nicole R LeBoeuf, Andrew A Lane
Organ Involvement in Adults with BPDCN is Associated with Sun Exposure History, TET2 and RAS Mutations, and Survival. Blood advances (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia 38 (3) (2024)
Peter S Winter, Michelle L Ramseier, Andrew W Navia, Sachit D Saksena, Haley Strouf, Nezha Senhaji, Alan DenAdel, Mahnoor Mirza, Hyun Hwan An, Laura Bilal, Peter Dennis, Catharine S Leahy, Kay Shigemori, Jennyfer Galves-Reyes, Ye Zhang, Foster Powers, Nolawit Mulugeta, Alejandro J Gupta, Nicholas L Calistri, Alexandria Van Scoyk, Kristen Jones, Huiyun Liu, Kristen E Stevenson, Siyang Ren, Marlise R Luskin, Charles P Couturier, Ava P Soleimany, Srivatsan Raghavan, Robert J Kimmerling, Mark M Stevens, Lorin Crawford, David M Weinstock, Scott R Manalis, Alex K Shalek, Mark A Murakami
Mutation and cell state compatibility is required and targetable in Ph + acute lymphoblastic leukemia minimal residual disease. bioRxiv : the preprint server for biology (2024)
Rahul S Vedula, Hannah Q Karp, Jeremy Koob, Felicia Lim, Jacqueline S Garcia, Eric S Winer, Marlise R Luskin, Gabriel Ghiaur, Annette S Kim, Lan W Beppu, Olga Sala-Torra, Jerald P Radich, Jonathan Samuel Gootenberg, Omar Abudayyeh, Feng Zhang, R Coleman Lindsley
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias. Blood (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Yannis K Valtis, Yael Flamand, Shai Shimony, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols. Leukemia 38 (3) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Peter S Winter, Michelle L Ramseier, Andrew W Navia, Sachit D Saksena, Haley Strouf, Nezha Senhaji, Alan DenAdel, Mahnoor Mirza, Hyun Hwan An, Laura Bilal, Peter Dennis, Catharine S Leahy, Kay Shigemori, Jennyfer Galves-Reyes, Ye Zhang, Foster Powers, Nolawit Mulugeta, Alejandro J Gupta, Nicholas L Calistri, Alexandria Van Scoyk, Kristen Jones, Huiyun Liu, Kristen E Stevenson, Siyang Ren, Marlise R Luskin, Charles P Couturier, Ava P Soleimany, Srivatsan Raghavan, Robert J Kimmerling, Mark M Stevens, Lorin Crawford, David M Weinstock, Scott R Manalis, Alex K Shalek, Mark A Murakami
Mutation and cell state compatibility is required and targetable in Ph + acute lymphoblastic leukemia minimal residual disease. bioRxiv : the preprint server for biology (2024)
Shai Shimony, Julia Keating, Christopher J Fay, Marlise R Luskin, Donna S Neuberg, Nicole R LeBoeuf, Andrew A Lane
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival. Blood advances 8 (11) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Peter S Winter, Michelle L Ramseier, Andrew W Navia, Sachit D Saksena, Haley Strouf, Nezha Senhaji, Alan DenAdel, Mahnoor Mirza, Hyun Hwan An, Laura Bilal, Peter Dennis, Catharine S Leahy, Kay Shigemori, Jennyfer Galves-Reyes, Ye Zhang, Foster Powers, Nolawit Mulugeta, Alejandro J Gupta, Nicholas L Calistri, Alexandria Van Scoyk, Kristen Jones, Huiyun Liu, Kristen E Stevenson, Siyang Ren, Marlise R Luskin, Charles P Couturier, Ava P Soleimany, Srivatsan Raghavan, Robert J Kimmerling, Mark M Stevens, Lorin Crawford, David M Weinstock, Scott R Manalis, Alex K Shalek, Mark A Murakami
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease. bioRxiv : the preprint server for biology (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia (2024)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Shai Shimony, Marlise R Luskin
Unraveling KMT2A-rearranged ALL. Blood 142 (21) (2023)
Shai Shimony, Geoffrey G Fell, Evan C Chen, Harrison K Tsai, Martha Wadleigh, Eric S Winer, Jacqueline S Garcia, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, R Coleman Lindsley, Richard M Stone
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients age ≥60 years. Blood advances (2023)
Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Richard M Stone, Martha Wadleigh, Donna S Neuberg, Daniel J DeAngelo, Marlise R Luskin
Effect of BMI on Toxicities and Survival Among Adolescents and Young Adults Treated on DFCI Consortium ALL Trials. Blood advances (2023)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle Dawn Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, Angela M Lager, Carrie Fitzpatrick, Jeremy P Segal, Mehdi Gharghabi, Sandeep K Gurbuxani, Girish Venkataraman, Jason X Cheng, Bartholomew J Eisfelder, Oliver Bohorquez, Anand Ashwin Patel, Sheethal Umesh Nagalakshmi, Savita Jayaram, Olatoyosi M Odenike, Richard A Larson, Lucy A Godley, Daniel A Arber, Christopher J Gibson, Nikhil C Munshi, Guido Marcucci, Benjamin L Ebert, John M Greally, Ulrich Steidl, Rosa Lapalombella, Bijal D Shah, Wendy Stock
Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood cancer discovery (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Jonathan D Paolino, Boris Dimitrov, Beth Apsel Winger, Angélica Sandoval-Pérez, Amith Vikram Rangarajan, Nicole Ocasio-Martinez, Harrison K Tsai, Yuting Li, Amanda L Robichaud, Delan Khalid, Charles Hatton, Riaz Gillani, Petri Polonen, Anthony Dilig, Giacomo Gotti, Julia Kavanagh, Asmani A Adhav, Sean Gow, Jonathan M Tsai, Yen-Der Li, Benjamin L Ebert, Eliezer Van Allen, Jacob R Bledsoe, Annette S Kim, Sarah K Tasian, Stacy L Cooper, Todd M Cooper, Nobuko Hijiya, Maria-Luisa Sulis, Neerav N Shukla, Jeffrey A Magee, Charles G Mullighan, Michael J Burke, Marlise R Luskin, Brenton G Mar, Matthew P Jacobson, Marian H Harris, Kimberly Stegmaier, Andrew E Place, Yana Pikman
Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ali AlJabban, Hyun-Il Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J DeAngelo, David M Dorfman, Benjamin L Ebert, Jacqueline S Garcia, Caron A Jacobson, Hakim Lakhani, Jacob P Laubach, Azra H Ligon, Neal I Lindeman, R Coleman Lindsley, Scott B Lovitch, Marlise R Luskin, Elizabeth A Morgan, Andrew Nowak, Athena Petrides, Geraldine S Pinkus, Olga Pozdnyakova, David P Steensma, Richard M Stone, Olga K Weinberg, Eric S Winer, Annette S Kim
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Andrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, Jada Lauren N Garzon, Ilene Galinsky, Emilie W Baxter, Rebecca Leonard, Daniel J DeAngelo, Marlise R Luskin, Christopher R Reilly, Maximilian Stahl, Richard M Stone, Rahul S Vedula, Martha Wadleigh, Eric S Winer, Tariq I Mughal, Christopher Brooks, Ira V Gupta, Kristen E Stevenson, Donna S Neuberg, Siyang Ren, Julia H Keating, Marina Y Konopleva, Anthony S Stein, Naveen Pemmaraju
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia. Blood advances (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Shai Shimony, Daniel J DeAngelo, Marlise R Luskin
Nelarabine: When, Where and How to Use it When Treating T-cell Acute Lymphoblastic Leukemia. Blood advances (2023)
Mingxing Teng, Marlise R Luskin, Sandra W Cowan-Jacob, Qiang Ding, Doriano Fabbro, Nathanael S Gray
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. Journal of medicinal chemistry 65 (11) (2022)
Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire, Mark G Faber, Rahul S Vedula, Anne Charles, Kevin M Copson, Shai Shimony, Alon Rozental, Pavan K Bendapudi, Ofir Wolach, Elizabeth A Griffiths, James E Thompson, Richard M Stone, Daniel J DeAngelo, Donna Neuberg, Marlise R Luskin, Eunice S Wang, R Coleman Lindsley
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood advances 6 (9) (2022)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Shai Shimony, Yiwen Liu, Yannis K Valtis, Jonathan D Paolino, Andrew E Place, Andrew M Brunner, Lachelle Dawn Weeks, Lewis B Silverman, Lynda M Vrooman, Donna Neuberg, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood advances (2022)
Marlise R Luskin
A challenging choice: consolidation in Ph+ ALL. Blood 140 (20) (2022)
Jacqueline S Garcia, Yael Flamand, Livius Penter, Michael Keng, Benjamin Tomlinson, Lourdes M Mendez, Paul B Koller, Nicole Cullen, Yohei Arihara, Kathleen Lindahl Pfaff, Jacquelyn O Wolff, Andrew M Brunner, Ilene Galinsky, Asad Bashey, Joseph H Antin, Corey S Cutler, Vincent T Ho, Brian A Jonas, Marlise R Luskin, Martha Wadleigh, Eric S Winer, Alexandra Savell, Rebecca Leonard, Taylor Robertson, Matthew S Davids, Howard Streicher, Scott J Rodig, Jerome Ritz, Catherine J Wu, Daniel J DeAngelo, Donna Neuberg, Richard M Stone, Robert J Soiffer
Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings. Blood (2022)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 5 (1) (2022)
Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas, Micah D Gearhart, Emmalee R Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie, Christopher J Gibson, Monica Schenone, H Moses Murdock, Eunice S Wang, Lukasz P Gondek, Martin P Carroll, Rahul S Vedula, Eric S Winer, Jacqueline S Garcia, Richard M Stone, Marlise R Luskin, Steven A Carr, Henry W Long, Vivian J Bardwell, Maria E Figueroa, R Coleman Lindsley
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes. Blood cancer discovery 3 (2) (2022)
Shai Shimony, Yiwen Liu, Yannis K Valtis, Jonathan D Paolino, Andrew E Place, Andrew M Brunner, Lachelle Dawn Weeks, Lewis B Silverman, Lynda M Vrooman, Donna Neuberg, Richard M Stone, Daniel J DeAngelo, Marlise R Luskin
Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood advances (2022)
Yannis K Valtis, Kristen E Stevenson, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Giacomo Gotti, Andrew M Brunner, Mary Nauffal, Daniel J DeAngelo, Marlise R Luskin
Orthopedic Toxicities Among Adolescents and Young Adults Treated on DFCI ALL Consortium Trials. Blood advances (2021)
Andrew Hantel, Marlise R Luskin, Jacqueline S Garcia, Wendy Stock, Daniel J DeAngelo, Gregory A Abel
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood advances 5 (21) (2021)
Sarah Beth Mueller, Paola Dal Cin, Long Phi Le, Dora Dias-Santagata, Jochen K Lennerz, Anthony John Iafrate, Hetal D Marble, Andrew M Brunner, Matthew Weinstock, Marlise R Luskin, Daniel J DeAngelo, Richard M Stone, Valentina Nardi
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. Blood advances (2021)